Dr Allan Douglas Nanney Iii, MD | |
2222 N Nevada Ave Ste 5001, Colorado Springs, CO 80907-6865 | |
(719) 776-3580 | |
(719) 776-3599 |
Full Name | Dr Allan Douglas Nanney Iii |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 2222 N Nevada Ave Ste 5001, Colorado Springs, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013238419 | NPI | - | NPPES |
49200062 | Medicaid | CO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 125055764 (Illinois) | Secondary |
207T00000X | Neurological Surgery | DR.0056991 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Allan Douglas Nanney Iii, MD 6653 Lookout Rd # A103, Boulder, CO 80301-3362 Ph: (704) 519-9162 | Dr Allan Douglas Nanney Iii, MD 2222 N Nevada Ave Ste 5001, Colorado Springs, CO 80907-6865 Ph: (719) 776-3580 |
News Archive
Canadian Prime Minister Stephen Harper "can use the relatively intimate setting of the G8's Muskoka meeting to press for a renewal of the G8's commitment to better health for Africans, and help the developed world be truly accountable for its promises," the Globe and Mail writes in an editorial. "The G8's failure to fully fund the historic aid commitments to Africa it made at the 2005 Gleneagles summit" puts the future success of the developing world at risk, the editorial states.
PregLem, the Swiss specialty biopharmaceutical company focused on women's reproductive medicine, announces a world-wide, exclusive in licensing agreement for Bentamapimod, a novel, orally active, Jun Kinase Inhibitor from Merck Serono for an undisclosed amount. PregLem will develop the compound for the prevention of post-surgical abdominal adhesions and endometriosis in patients with tubal ligation or comparable effective contraception.
Results of the randomized, phase III, EORTC/GIMEMA 06012 intergroup trial (AML-17) reported in the Journal of Clinical Oncology show that sequential combination of gemtuzumab ozogamicin (GO) and standard chemotherapy provides no benefit for older patients with acute myeloid leukemia (AML) and is too toxic for patients 70 years of age or more. GO is an antibody-drug conjugate comprised of an anti-CD33 monoclonal antibody linked to a cytotoxic agent.
MDxHealth SA, a leading molecular diagnostics company in the field of personalized cancer treatment, today announced that together with partner NovioGendix B.V., a molecular diagnostics company spun out from Radboud University Nijmegen Medical Centre, the Netherlands, has received a USD 1.1 million grant from Eurotrans-Bio to progress its bladder cancer program.
› Verified 9 days ago
Michael W Brown, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2312 N Nevada Ave, Suite 100, Colorado Springs, CO 80907 Phone: 719-473-3272 Fax: 719-389-1191 | |
Mr. Shervin Rahimpour, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5544 Saxon Ln, Colorado Springs, CO 80918 Phone: 719-290-2827 | |
Dr. Rahul Singh, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1725 E Boulder St Ste 101, Colorado Springs, CO 80909 Phone: 719-365-6300 Fax: 719-365-6094 | |
Nicholas Maurio, NP Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 8540 Scarborough Dr Ste 100, Colorado Springs, CO 80920 Phone: 719-955-4200 Fax: 719-365-7667 | |
Donald James Sceats Jr., M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2312 N Nevada Ave, Suite 100, Colorado Springs, CO 80907 Phone: 719-473-3272 Fax: 719-389-1191 | |
Dr. Todd Palmer Thompson, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1725 E Boulder St, Suite 101, Colorado Springs, CO 80909 Phone: 719-365-6300 Fax: 719-365-6094 |